Cotización Cardio Diagnostics - CDIO

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Último Precio

0.4802

Postura de Compra

0.4802

Postura de Venta

0.50

Volume Operado de la Acción

1,186,837

0.4502 Rango del Día 0.5242

0.19 Rango de 52 semanas 1.86

Capitalización de Mercado [m]

19.419M

Precio Anterior

0.50

Precio de Apertura

0.519

Hora

2000

0.4802

(formt)

Última hora de negociación

Volumen financiero

US$ 570,614

Precio Promedio Ponderado

0.480785

Volumen promedio (3 m)

6,738,751

Acciones en circulación

40,439,810

Rendimiento del Dividendo

Ratio Precio/Utilidad

-2.37

Beneficio por acción (BPA)

-0.21

turnover

17k

Beneficio neto

-8.38M

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenet... Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assists in the treatment of cardiovascular disease. Mostrar más

Sector

Blank Checks

Industria

In Vitro,in Vivo Diagnostics

Sede

Dover, Delaware, USA

Fundado

2021

Cardio Diagnostics Holdings Inc is listed in the Blank Checks sector of the NASDAQ with ticker CDIO. The last closing price for Cardio Diagnostics was US$0.50. Over the last year, Cardio Diagnostics shares have traded in a share price range of US$ 0.19 to US$ 1.86.

Cardio Diagnostics currently has 40,439,810 shares in issue. The market capitalisation of Cardio Diagnostics is US$20.22 million. Cardio Diagnostics has a price to earnings ratio (PE ratio) of -2.37.

Cardio Diagnostics Expands the Reach of its AI-Driven Precision Cardiovascular Medicine Tests by Partnering with Seven New Provider Organizations

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), an AI-driven Precision Cardiovascular Medicine company, today announced that the Company has...

Cardio Diagnostics Holdings, Inc. Receives Final Medicare Pricing Determination from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc. (NASDAQ:...

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Solutions at the FLAACOs Annual Conference

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, today announced it will sponsor and...

Cardio Diagnostics Holdings, Inc. Receives Preliminary Medicare Pricing from Centers for Medicare and Medicaid Services (CMS) for AI-Powered Cardiovascular Tests

Preliminary CMS pricing determination marks a key milestone in gaining broad access to Medicare reimbursement. Cardio Diagnostics Holdings, Inc...

Cardio Diagnostics Holdings Inc. Launches CDIO.AI, A Redesigned Website Enhancing User Experience and Highlighting Our AI-Driven Cardiovascular Solutions

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-powered precision cardiovascular medicine, today announced the launch of its...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s...

Cardio Diagnostics Announces Its Epi+Gen CHD Heart Attack Risk Assessment Test is Now Available at Meijer Supercenter in McHenry, Illinois

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company’s...

Cardio Diagnostics Announces It’s Exhibiting at the 2024 Onsite Employee Health Clinics Forum

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), an AI-driven precision cardiovascular medicine company, announced today that the Company will...

Cardio Diagnostics Holdings, Inc. Achieves SOC 2 Type I Compliance Certification for Security and Confidentiality

Cardio Diagnostics Holdings, Inc. (NASDAQ: CDIO), a leader in AI-driven precision cardiovascular medicine, today announced the successful...

Cardio Diagnostics to Participate in the Centers for Medicare and Medicaid Services’ (CMS) Clinical Laboratory Fee Schedule (CLFS) Annual Meeting to Secure Medicare Payment for Its Innovative Tests

Company to recommend pricing for its Epi+Gen CHD and PrecisionCHD tests, and pursue coverage via the Molecular Diagnostic Services (MolDx...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.1798	-27.2424242424	0.66	0.678	0.4683	2033448	0.52224476	CS
4	0.0399	9.06200317965	0.4403	0.685	0.4121	2376803	0.53639311	CS
12	0.1702	54.9032258065	0.31	1.77	0.277	6738751	0.75297775	CS
26	0.0502	11.6744186047	0.43	1.77	0.19	4490586	0.59414697	CS
52	-1.3198	-73.3222222222	1.8	1.86	0.19	2437578	0.61967257	CS
156	-3.7698	-88.7011764706	4.25	8.4999	0.171	3143074	1.58784673	CS
260	-3.7698	-88.7011764706	4.25	8.4999	0.171	3143074	1.58784673	CS

CDIO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Cardio Diagnostics?

El precio actual de las acciones de Cardio Diagnostics es US$ 0.4802

¿Cuántas acciones de Cardio Diagnostics están en circulación?

Cardio Diagnostics tiene 40,439,810 acciones en circulación

¿Cuál es la capitalización de mercado de Cardio Diagnostics?

La capitalización de mercado de Cardio Diagnostics es USD 20.22M

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Cardio Diagnostics?

Cardio Diagnostics ha negociado en un rango de US$ 0.19 a US$ 1.86 durante el último año

¿Cuál es el ratio PE (precio/beneficio) de Cardio Diagnostics?

El ratio precio/beneficio de Cardio Diagnostics es -2.37

¿Cuál es el ratio de efectivo a ventas de Cardio Diagnostics?

El ratio de efectivo a ventas de Cardio Diagnostics es 1.23k

¿Cuál es la moneda de reporte de Cardio Diagnostics?

Cardio Diagnostics presenta sus resultados financieros en USD

¿Cuál es el último ingresos anual de Cardio Diagnostics?

El último ingresos anual de Cardio Diagnostics es USD 17k

¿Cuál es el último beneficio anual de Cardio Diagnostics?

El último beneficio anual de Cardio Diagnostics es USD -8.38M

¿Cuál es la dirección registrada de Cardio Diagnostics?

La dirección registrada de Cardio Diagnostics es 8 THE GREEN, SUITE #12490, DOVER, DELAWARE, 19901

¿En qué sector industrial opera Cardio Diagnostics?

Cardio Diagnostics opera en el sector IN VITRO,IN VIVO DIAGNOSTICS

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
ONVOOrganovo Holdings Inc	US$ 1.2502 (238.81%)	386.27M
RETOReTo Eco Solutions Inc	US$ 1.065 (80.51%)	78.71M
VEROVenus Concept Inc	US$ 0.5402 (76.54%)	15.55M
SLXNSilexion Therapeutics Corporation	US$ 1.23 (64.00%)	87.74M
WAFUWah Fu Education Group Ltd	US$ 2.825 (57.82%)	125.46M
YYAIConnexa Sports Technologies Inc	US$ 0.681 (-46.38%)	6.22M
RNAZTransCode Therapeutics Inc	US$ 4.34 (-35.99%)	611.44k
ACONAclarion Inc	US$ 3.25 (-30.26%)	417.53k
BTDRBitdeer Technologies Group	US$ 9.255 (-29.35%)	16.96M
NKLANikola Corporation	US$ 0.184 (-28.35%)	37.07M
ONVOOrganovo Holdings Inc	US$ 1.2502 (238.81%)	386.27M
NVDANVIDIA Corporation	US$ 126.63 (-2.80%)	271.57M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 14.41 (-16.85%)	167.52M
SMCISuper Micro Computer Inc	US$ 45.54 (-11.76%)	146.56M
TSLATesla Inc	US$ 302.80 (-8.39%)	134.25M